Ignite Creation Date:
2024-05-06 @ 12:03 AM
Last Modification Date:
2024-10-26 @ 10:43 AM
Study NCT ID:
NCT01472458
Status:
COMPLETED
Last Update Posted:
2017-02-06
First Post:
2011-08-02
Brief Title:
Premature Termination of Resuscitation in Survivors of Cardiac Arrest
Sponsor:
Sunnybrook Health Sciences Centre
Organization:
Sunnybrook Health Sciences Centre
Study Overview
Official Title:
Premature Termination of Resuscitation in Survivors of Cardiac Arrest
Status:
COMPLETED
Status Verified Date:
2017-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PremaTOR
Brief Summary:
The study Premature Termination of Resuscitation in Survivors of Cardiac Arrest focuses on using innovative knowledge translation strategies to improve appropriate neuroprognostication for survivors of cardiac arrest and prevent premature termination of life sustaining therapies This is important because any early gains achieved during resuscitation will be nullified if clinicians terminate life-sustaining therapies prematurely based on inadequate prognostic information An effective translation strategy for neuroprognostication will result in improved physician adherence to evidence-based medicine and an increase in the proportion of patients surviving to achieve a good neurological outcome following cardiac arrest
Detailed Description:
A stepped wedge cluster randomized trial design will be employed in order to properly evaluate the impact of this intervention Each of the 18 participating hospitals will be randomized one of the four wedges according to a random schedule each wedge will consist of 4 to 5 hospitals With this design the implementation of the intervention will be rolled out sequentially to the participating hospitals over a 5 month period for each wedge All hospitals will have received the intervention by the end of the study
Note that the study design fields provided by ClinicalTrialsgov do not allow for describing this type of study design therefore the investigators have listed the study as a single arm In reality this study will have 4 wedges each containing randomized clusters of 4-5 hospitals
Note that the study design fields provided by ClinicalTrialsgov do not allow for describing this type of study design therefore the investigators have listed the study as a single arm In reality this study will have 4 wedges each containing randomized clusters of 4-5 hospitals
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None